{"id":3766,"date":"2026-11-17T18:40:15","date_gmt":"2026-11-17T18:40:15","guid":{"rendered":"https:\/\/tansan.com.tr\/?page_id=3766"},"modified":"2026-11-17T20:33:03","modified_gmt":"2026-11-17T20:33:03","slug":"akciger-kanseri-tedavisinde-yeni-gelismeler","status":"publish","type":"page","link":"https:\/\/tansan.com.tr\/en\/akciger-kanseri-tedavisinde-yeni-gelismeler\/","title":{"rendered":"New Developments in Lung Cancer Treatment"},"content":{"rendered":"<p>Akci\u011fer kanseri tedavisinde son y\u0131llarda \u00f6nemli de\u011fi\u015fiklikler oldu. Art\u0131k yaln\u0131zca hastal\u0131\u011f\u0131n hangi evrede oldu\u011funa de\u011fil, kanser h\u00fccrelerinin \u00f6zelliklerine de bakarak daha ayr\u0131nt\u0131l\u0131 bir tedavi plan\u0131 yapabiliyoruz. Bu nedenle ilk ad\u0131m, do\u011fru patolojik tan\u0131 ve evrelemeyle birlikte hastan\u0131n farkl\u0131 uzmanlar taraf\u0131ndan de\u011ferlendirilmesidir. K\u00fc\u00e7\u00fck h\u00fccreli ve k\u00fc\u00e7\u00fck h\u00fccreli d\u0131\u015f\u0131 akci\u011fer kanserinin tedavileri birbirinden farkl\u0131d\u0131r; hastan\u0131n genel sa\u011fl\u0131\u011f\u0131 ve beklentileri de kararlara y\u00f6n verir. [1]\n<p>K\u00fc\u00e7\u00fck h\u00fccreli d\u0131\u015f\u0131 akci\u011fer kanserinde molek\u00fcler incelemeler, tedavi se\u00e7iminin \u00f6nemli bir par\u00e7as\u0131d\u0131r. EGFR, ALK, ROS1, RET, MET, BRAF, HER2 ve KRAS gibi genlerdeki de\u011fi\u015fikliklerin ara\u015ft\u0131r\u0131lmas\u0131, uygun hastalarda hedefe y\u00f6nelik ila\u00e7lar\u0131n \u00f6n\u00fcn\u00fc a\u00e7abilir. PD-L1 incelemesi de imm\u00fcnoterapi karar\u0131na yard\u0131mc\u0131 olur. Bu testler birbirinin yerine ge\u00e7mez; sonu\u00e7lar\u0131 birlikte de\u011ferlendirmek, tedavinin ba\u015f\u0131nda do\u011fru se\u00e7ene\u011fe y\u00f6nelmeyi sa\u011flar. [1]\n<p>Ameliyat edilebilir hastal\u0131kta cerrahi \u00f6nemini korurken, se\u00e7ilmi\u015f hastalarda ameliyat \u00f6ncesi kemoterapiye imm\u00fcnoterapi eklenmesi ve ameliyat sonras\u0131nda imm\u00fcnoterapinin s\u00fcrd\u00fcr\u00fclmesi, hastal\u0131\u011f\u0131n tekrarlama riskini azaltabiliyor. AEGEAN \u00e7al\u0131\u015fmas\u0131n\u0131n 2026 g\u00fcncellemesi bu yakla\u015f\u0131m\u0131 destekliyor. Ameliyat edilemeyen evre III hastal\u0131kta ise belirli EGFR mutasyonlar\u0131 bulunan ve kemoradyoterapi sonras\u0131nda hastal\u0131\u011f\u0131 ilerlemeyen ki\u015filerde osimertinib, hastal\u0131\u011f\u0131n ilerlemeden kontrol alt\u0131nda kald\u0131\u011f\u0131 s\u00fcreyi uzatan bir se\u00e7enek olarak yerini ald\u0131. [2,3]\n<p>\u0130leri evrede hedefe y\u00f6nelik tedaviler geli\u015fmeye devam ediyor. \u00d6rne\u011fin 2026\u2019da sevabertinib, belirli HER2 mutasyonlar\u0131 ta\u015f\u0131yan ileri evre k\u00fc\u00e7\u00fck h\u00fccreli d\u0131\u015f\u0131 akci\u011fer kanserinde ilk tedavi se\u00e7ene\u011fi olarak ABD\u2019de h\u0131zland\u0131r\u0131lm\u0131\u015f onay ald\u0131. Yine 2026\u2019da yay\u0131mlanan Krascendo 1 \u00e7al\u0131\u015fmas\u0131nda, daha \u00f6nce tedavi g\u00f6rm\u00fc\u015f KRAS G12C mutasyonlu hastalarda divarasib, kar\u015f\u0131la\u015ft\u0131r\u0131lan \u00f6nceki nesil ila\u00e7lara g\u00f6re daha uzun hastal\u0131k kontrol\u00fc sa\u011flad\u0131. Bu yeni ara\u015ft\u0131rma sonucu, her \u00fclkede rutin kullan\u0131ma a\u00e7\u0131ld\u0131\u011f\u0131 anlam\u0131na gelmiyor. [4,5]\n<p>Antikora ba\u011fl\u0131 kemoterapiler de yeni se\u00e7enekler aras\u0131nda. Antikor ila\u00e7 konjugat\u0131 olan datopotamab derukstekan, EGFR mutasyonlu ileri evre hastal\u0131kta, EGFR\u2019ye y\u00f6nelik ila\u00e7 ve platinli kemoterapi sonras\u0131nda ABD\u2019de h\u0131zland\u0131r\u0131lm\u0131\u015f onay alan tedavilerden biri. Burada ama\u00e7, kemoterapiyi t\u00fcm\u00f6r h\u00fccresindeki belirli bir hedefe ta\u015f\u0131mak; ancak yan etki takibi yine gerekli. [6]\n<p>K\u00fc\u00e7\u00fck h\u00fccreli akci\u011fer kanserinde de ilerleme var. S\u0131n\u0131rl\u0131 evrede kemoradyoterapi sonras\u0131nda hastal\u0131\u011f\u0131 ilerlemeyen ki\u015filerde durvalumab ya\u015fam s\u00fcresini uzatabiliyor. Yayg\u0131n evrede, platinli tedavi sonras\u0131nda ilerleyen hastal\u0131kta kullan\u0131lan tarlatamab ise ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccreleriyle kanser h\u00fccrelerini bulu\u015fturan \u00e7ift \u00f6zg\u00fcll\u00fc bir antikor. 2026 DeLLphi-305 \u00e7al\u0131\u015fmas\u0131, ilk kemoterapi ve imm\u00fcnoterapi sonras\u0131nda hastal\u0131\u011f\u0131 ilerlemeyen ki\u015filerde tarlatamab\u0131n durvalumaba eklenmesiyle ya\u015fam s\u00fcresinde iyile\u015fme bildirdi; bu sonu\u00e7 yeni bir idame tedavisi yakla\u015f\u0131m\u0131n\u0131 g\u00fcndeme getiriyor. [7\u20139]\n<p>B\u00fct\u00fcn bu se\u00e7enekler, her hastaya ayn\u0131 tedavinin uygun oldu\u011fu anlam\u0131na gelmez. As\u0131l hedef, g\u00fcncel bilgiyi ki\u015finin durumuyla birle\u015ftirerek beklenen yarar\u0131, olas\u0131 yan etkileri ve T\u00fcrkiye\u2019deki eri\u015fim ko\u015fullar\u0131n\u0131 birlikte de\u011ferlendirmek; hastan\u0131n g\u00fcnl\u00fck ya\u015fam\u0131n\u0131 da g\u00f6zeten bir yol \u00e7izmektir.<\/p>\n<p><strong>Kaynaklar \u00a0<\/strong><a href=\"https:\/\/www.cancer.gov\/types\/lung\/hp\/non-small-cell-lung-treatment-pdq\">[1] NCI \u00b7 NSCLC<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO-25-02659\">[2] AEGEAN \u00b7 2026<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2402614\">[3] LAURA \u00b7 NEJM<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.bayer.com\/media\/en-us\/us-fda-grants-accelerated-approval-to-bayers-targeted-therapy-sevabertinib-as-a-first-line-treatment-option-for-adults-with-her2-mutant-non-small-cell-lung-cancer\/\">[4] HER2 \u00b7 2026<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2605703\">[5] Krascendo 1 \u00b7 2026<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/761464s000lbl.pdf\">[6] FDA \u00b7 ADC<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2404873\">[7] ADRIATIC \u00b7 NEJM<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJMoa2502099\">[8] DeLLphi-304 \u00b7 NEJM<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/42929702\/\">[9] DeLLphi-305 \u00b7 2026<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Akci\u011fer kanseri tedavisinde son y\u0131llarda \u00f6nemli de\u011fi\u015fiklikler oldu. Art\u0131k yaln\u0131zca hastal\u0131\u011f\u0131n hangi evrede oldu\u011funa de\u011fil, kanser h\u00fccrelerinin \u00f6zelliklerine de bakarak daha ayr\u0131nt\u0131l\u0131 bir tedavi plan\u0131 yapabiliyoruz. Bu nedenle ilk ad\u0131m, do\u011fru patolojik tan\u0131 ve evrelemeyle birlikte hastan\u0131n farkl\u0131 uzmanlar taraf\u0131ndan de\u011ferlendirilmesidir. K\u00fc\u00e7\u00fck h\u00fccreli ve k\u00fc\u00e7\u00fck h\u00fccreli d\u0131\u015f\u0131 akci\u011fer kanserinin tedavileri birbirinden farkl\u0131d\u0131r; hastan\u0131n genel sa\u011fl\u0131\u011f\u0131<\/p>","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3766","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Akci\u011fer Kanseri Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tansan.com.tr\/en\/akciger-kanseri-tedavisinde-yeni-gelismeler\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Akci\u011fer Kanseri Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi\" \/>\n<meta property=\"og:description\" content=\"Akci\u011fer kanseri tedavisinde son y\u0131llarda \u00f6nemli de\u011fi\u015fiklikler oldu. Art\u0131k yaln\u0131zca hastal\u0131\u011f\u0131n hangi evrede oldu\u011funa de\u011fil, kanser h\u00fccrelerinin \u00f6zelliklerine de bakarak daha ayr\u0131nt\u0131l\u0131 bir tedavi plan\u0131 yapabiliyoruz. Bu nedenle ilk ad\u0131m, do\u011fru patolojik tan\u0131 ve evrelemeyle birlikte hastan\u0131n farkl\u0131 uzmanlar taraf\u0131ndan de\u011ferlendirilmesidir. K\u00fc\u00e7\u00fck h\u00fccreli ve k\u00fc\u00e7\u00fck h\u00fccreli d\u0131\u015f\u0131 akci\u011fer kanserinin tedavileri birbirinden farkl\u0131d\u0131r; hastan\u0131n genel sa\u011fl\u0131\u011f\u0131\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tansan.com.tr\/en\/akciger-kanseri-tedavisinde-yeni-gelismeler\/\" \/>\n<meta property=\"og:site_name\" content=\"\u00d6zel Tansan Poliklini\u011fi\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-17T20:33:03+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tansan.com.tr\/akciger-kanseri-tedavisinde-yeni-gelismeler\/\",\"url\":\"https:\/\/tansan.com.tr\/akciger-kanseri-tedavisinde-yeni-gelismeler\/\",\"name\":\"Akci\u011fer Kanseri Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi\",\"isPartOf\":{\"@id\":\"https:\/\/tansan.com.tr\/#website\"},\"datePublished\":\"2026-11-17T18:40:15+00:00\",\"dateModified\":\"2026-11-17T20:33:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/tansan.com.tr\/akciger-kanseri-tedavisinde-yeni-gelismeler\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tansan.com.tr\/akciger-kanseri-tedavisinde-yeni-gelismeler\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tansan.com.tr\/akciger-kanseri-tedavisinde-yeni-gelismeler\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Ana sayfa\",\"item\":\"https:\/\/tansan.com.tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Akci\u011fer Kanseri Tedavisinde Yeni Geli\u015fmeler\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tansan.com.tr\/#website\",\"url\":\"https:\/\/tansan.com.tr\/\",\"name\":\"Tansan Onkoloji - \u00d6zel Tansan Poliklini\u011fi\",\"description\":\"Kanser Te\u015fhis ve Tedavisi\",\"publisher\":{\"@id\":\"https:\/\/tansan.com.tr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tansan.com.tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/tansan.com.tr\/#organization\",\"name\":\"\u00d6zel Tansan Onkoloji Poliklini\u011fi\",\"url\":\"https:\/\/tansan.com.tr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/tansan.com.tr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/tansan.com.tr\/wp-content\/uploads\/2020\/02\/TansanLogo-1.png\",\"contentUrl\":\"https:\/\/tansan.com.tr\/wp-content\/uploads\/2020\/02\/TansanLogo-1.png\",\"width\":274,\"height\":66,\"caption\":\"\u00d6zel Tansan Onkoloji Poliklini\u011fi\"},\"image\":{\"@id\":\"https:\/\/tansan.com.tr\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Akci\u011fer Kanseri Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tansan.com.tr\/en\/akciger-kanseri-tedavisinde-yeni-gelismeler\/","og_locale":"en_GB","og_type":"article","og_title":"Akci\u011fer Kanseri Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi","og_description":"Akci\u011fer kanseri tedavisinde son y\u0131llarda \u00f6nemli de\u011fi\u015fiklikler oldu. Art\u0131k yaln\u0131zca hastal\u0131\u011f\u0131n hangi evrede oldu\u011funa de\u011fil, kanser h\u00fccrelerinin \u00f6zelliklerine de bakarak daha ayr\u0131nt\u0131l\u0131 bir tedavi plan\u0131 yapabiliyoruz. Bu nedenle ilk ad\u0131m, do\u011fru patolojik tan\u0131 ve evrelemeyle birlikte hastan\u0131n farkl\u0131 uzmanlar taraf\u0131ndan de\u011ferlendirilmesidir. K\u00fc\u00e7\u00fck h\u00fccreli ve k\u00fc\u00e7\u00fck h\u00fccreli d\u0131\u015f\u0131 akci\u011fer kanserinin tedavileri birbirinden farkl\u0131d\u0131r; hastan\u0131n genel sa\u011fl\u0131\u011f\u0131","og_url":"https:\/\/tansan.com.tr\/en\/akciger-kanseri-tedavisinde-yeni-gelismeler\/","og_site_name":"\u00d6zel Tansan Poliklini\u011fi","article_modified_time":"2026-11-17T20:33:03+00:00","twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tansan.com.tr\/akciger-kanseri-tedavisinde-yeni-gelismeler\/","url":"https:\/\/tansan.com.tr\/akciger-kanseri-tedavisinde-yeni-gelismeler\/","name":"Akci\u011fer Kanseri Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi","isPartOf":{"@id":"https:\/\/tansan.com.tr\/#website"},"datePublished":"2026-11-17T18:40:15+00:00","dateModified":"2026-11-17T20:33:03+00:00","breadcrumb":{"@id":"https:\/\/tansan.com.tr\/akciger-kanseri-tedavisinde-yeni-gelismeler\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tansan.com.tr\/akciger-kanseri-tedavisinde-yeni-gelismeler\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/tansan.com.tr\/akciger-kanseri-tedavisinde-yeni-gelismeler\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Ana sayfa","item":"https:\/\/tansan.com.tr\/"},{"@type":"ListItem","position":2,"name":"Akci\u011fer Kanseri Tedavisinde Yeni Geli\u015fmeler"}]},{"@type":"WebSite","@id":"https:\/\/tansan.com.tr\/#website","url":"https:\/\/tansan.com.tr\/","name":"Tansan Oncology - Tansan Private Polyclinic","description":"Cancer Diagnosis and Treatment","publisher":{"@id":"https:\/\/tansan.com.tr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tansan.com.tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/tansan.com.tr\/#organization","name":"Tansan Private Oncology Polyclinic","url":"https:\/\/tansan.com.tr\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/tansan.com.tr\/#\/schema\/logo\/image\/","url":"https:\/\/tansan.com.tr\/wp-content\/uploads\/2020\/02\/TansanLogo-1.png","contentUrl":"https:\/\/tansan.com.tr\/wp-content\/uploads\/2020\/02\/TansanLogo-1.png","width":274,"height":66,"caption":"\u00d6zel Tansan Onkoloji Poliklini\u011fi"},"image":{"@id":"https:\/\/tansan.com.tr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/pages\/3766","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/comments?post=3766"}],"version-history":[{"count":2,"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/pages\/3766\/revisions"}],"predecessor-version":[{"id":3800,"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/pages\/3766\/revisions\/3800"}],"wp:attachment":[{"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/media?parent=3766"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}